SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-267144
Filing Date
2022-10-24
Accepted
2022-10-24 07:59:05
Documents
15
Period of Report
2022-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d389595d8k.htm   iXBRL 8-K 42712
2 EX-10.1 d389595dex101.htm EX-10.1 27682
3 EX-10.2 d389595dex102.htm EX-10.2 64157
4 EX-10.3 d389595dex103.htm EX-10.3 15354
  Complete submission text file 0001193125-22-267144.txt   301869

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221024.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221024_lab.xml EX-101.LAB 17996
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221024_pre.xml EX-101.PRE 11257
9 EXTRACTED XBRL INSTANCE DOCUMENT d389595d8k_htm.xml XML 3399
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221324848
SIC: 2834 Pharmaceutical Preparations